Login / Signup

Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay.

Connie H Miller
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)
VWF inhibitors can be quantitatively monitored in VWD3 patients. Preanalytical heat treatment may be required for their detection post infusion.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • high throughput
  • prognostic factors
  • mass spectrometry
  • combination therapy
  • patient reported outcomes
  • label free
  • single cell